Drug versus vaccine investment: a modelled comparison of economic incentives

BACKGROUND: Investment by manufacturers in research and development of vaccines is relatively low compared with that of pharmaceuticals. If current evaluation technologies favour drugs over vaccines, then the vaccines market becomes relatively less attractive to manufacturers. METHODS: We developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Régnier, Stéphane A, Huels, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846654/
https://www.ncbi.nlm.nih.gov/pubmed/24011090
http://dx.doi.org/10.1186/1478-7547-11-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846654/
https://www.ncbi.nlm.nih.gov/pubmed/24011090
http://dx.doi.org/10.1186/1478-7547-11-23

Ejemplares similares